Clinical trials
Phase 4 Prostatic Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
49 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 2 |
| 2007 | 2 |
| 2009 | 3 |
| 2010 | 2 |
| 2011 | 3 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 2 |
| 2019 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 4 |
| 2024 | 7 |
| 2025 | 1 |
| 2026 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 20 |
| Recruiting | 9 |
| Terminated | 8 |
| Active, not recruiting | 4 |
| Unknown status | 3 |
| Not yet recruiting | 2 |
| Suspended | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Blue Earth Diagnostics | 2 |
| Brigham and Women's Hospital | 2 |
| GlaxoSmithKline | 2 |
| Johns Hopkins University | 2 |
| M.D. Anderson Cancer Center | 2 |
| Mayo Clinic | 2 |
| Northwestern University | 2 |
| Albany Medical College | 1 |
| Albert DeNittis | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Prostatic Neoplasms | 49 |
| Neoplasms | 6 |
| Kidney Diseases | 3 |
| Breast Neoplasms | 2 |
| Erectile Dysfunction | 2 |
| Hot Flashes | 2 |
| Hypertension | 2 |
| Kidney Neoplasms | 2 |
| Neoplasm Metastasis | 2 |
| Neuroendocrine Tumors | 2 |
Trials
Showing 1 to 25 of 49. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.